RxDoctor Payments Data

Bobbie Oshall

Nurse Practitioner · State College, PANPI 1659676955

Payments from drug & device makers

$303in general payments, 2019–2025

Across 18 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$53
  • AstraZeneca$51
  • Pfizer$33
  • Lilly USA, LLC$27
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$22
  • Otsuka America Pharmaceutical, Inc.$21
  • plus $96 from 6 others

What the payments were for

  • Food & beverage$303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$303 in reported general payments places this provider in the 65th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$66,761
Medicare patients
256
Services billed
1,252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine12$204,531
EliquisApixaban69$36,219
JardianceEmpagliflozin36$27,915
RybelsusSemaglutide13$11,762
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,388
XareltoRivaroxaban12$8,780
Pantoprazole Sodium86$1,972
Atorvastatin Calcium89$1,146
Lorazepam81$1,098
Levothyroxine Sodium86$1,079
Potassium Chloride65$1,075
Tramadol Hcl69$986
Tamsulosin Hcl45$874
Mirtazapine36$803
Oxycodone Hcl36$768

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$33$36,21969 claims
Novo NordiskRybelsus$53$11,76213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,059 nurse practitioner providers in Pennsylvania.

Other nurse practitioner in State College

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →